Inhibition of P 32 incorporation in vitro into nucleic acids of Ehrlich carcinoma cells by quinoline derivatives.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D009369:Neoplasms / Q000378:metabolism*; D009696:Nucleic Acids / Q000378:metabolism*; D010758:Phosphorus / Q000378:metabolism*; D011804:Quinolines / Q000494:pharmacology*
D000970:Antineoplastic Agents; D009696:Nucleic Acids; D011804:Quinolines; D010758:Phosphorus; C037219:quinoline
CYTOTOXIC DRUGS/effects; NEOPLASMS/metabolism; NUCLEIC ACIDS/metabolism; PHOSPHORUS/metabolism; QUINOLINES/effects